120550-58-5Relevant articles and documents
BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS
-
Page/Page column 200; 355-356, (2021/04/17)
Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula I as follows: Formula I wherein R1, R2, R3, and Q are defined herein.
Pyrazolopyrrolidine Derivatives and their Use in the Treatment of Disease
-
Paragraph 0507; 0508, (2014/12/09)
The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
AZAINDAZOLES
-
Page/Page column 203-204, (2013/03/28)
Herein are disclosed azaindazoles of formula (I), (I), where the various groups are defined herein, and which are useful for treating cancer.